YELITZA CASTANOS: Open Payments
NPI 1023376613 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$642 in 26 payments from 6 companies in 2025. Trend: 2023 $650 · 2024 $33 · 2025 $642
Food & beverage: $642
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $163 |
| Alnylam Pharmaceuticals Inc. | 5 | $158 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $117 |
| BridgeBio Pharma, Inc. | 4 | $105 |
| Novo Nordisk Inc | 3 | $86 |
| Lilly USA, LLC | 1 | $14 |
Products named: AMVUTTRA, WAINUA, JARDIANCE, Attruby, Wegovy, Ozempic, MOUNJARO.
Industry payments across NY — which companies pay providers there.
